Corneal Macular Dystrophy is a genetic eye disorder characterized by the gradual formation and deposition of abnormal protein aggregates in the cornea, leading to a loss of clarity and visual impairment. It is a type of corneal dystrophy that primarily affects the central part of the cornea known as the macula.
The cornea is the clear outer layer of the eye responsible for refracting light and focusing it onto the retina. In individuals with Corneal Macular Dystrophy, the abnormal protein deposits disrupt the normal structure of the cornea, causing it to become progressively clouded and opaque. This results in blurred vision, increased sensitivity to light, and a decrease in visual acuity over time.
Corneal Macular Dystrophy is typically an inherited condition, passing down from affected parents to their children through autosomal dominant inheritance. However, in some cases, it can also arise spontaneously without any family history.
Currently, there is no known cure for Corneal Macular Dystrophy. Treatment options focus on symptom management and may include the use of specialized contact lenses, prescription eyeglasses, or surgical interventions such as corneal transplantation. Regular follow-up with an ophthalmologist is necessary to monitor the progression of the disease and adjust treatment strategies accordingly.
Overall, Corneal Macular Dystrophy is a progressive eye disorder characterized by the accumulation of abnormal proteins in the cornea, resulting in vision impairment and a decline in visual acuity.
